<DOC>
	<DOCNO>NCT01935115</DOCNO>
	<brief_summary>To determine effect ketamine , compare propofol , use anesthetic agent electroconvulsive therapy ( ECT ) treatment major depressive disorder ( MDD ) . We hypothesize ketamine , compare propofol , improve symptom MDD use anesthetic agent facilitate ECT . Additionally , hypothesize dissociative cardiovascular effect ketamine minimal .</brief_summary>
	<brief_title>Comparing Ketamine Propofol Anesthesia Electroconvulsive Therapy</brief_title>
	<detailed_description>Treatment resistant depression common disable condition . The delayed onset action side effect exhibit oral antidepressant significant limitation . An alternative well-established therapy electroconvulsive therapy ( ECT ) . ECT rapid antidepressant effect begin completion first session . Nevertheless , like oral medication , patient treat ECT develop treatment resistance failure respond . There great need novel approach treatment-resistant depression ; one safe , rapid onset , sustain . Pharmaceutical agent rapid antidepressant effect new promise paradigm research treatment MDD . A potential therapeutic target glutamate base signal transmission glutamate transmission abnormally regulate limbic/cortical area many depressed people . Glutamatergic modulate agent , particular ketamine , show induce rapid antidepressant effect preclinical model human . Additionally , ketamine show persistent antidepressive effect . Presently worldwide , propofol one commonly use anesthetic agent ECT . There 2 main disadvantage practice . First , propofol antidepressive effect . Second , propofol potent anticonvulsant may worsen quality ECT induce seizure . A recent open-label trial compare ketamine propofol anesthesia ECT demonstrate significant improvement depression ketamine arm . Ketamine routinely use provide safe general anesthesia well procedural sedation , analgesia , amnesia . The combination intrinsic antidepressant effect ketamine electroconvulsive therapy promising concept clinical research .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Fulfill diagnostic criterion major depression accord Diagnostic Statistical Manual Mental Disorders ( recent edition ) Failure respond least 2 adequate drug therapy current depression episode MADRS score 20 ( moderate severe ASA physical status classification I III Inability obtain informed consent ASA physical status classification IV Complication serious physical disease cardiovascular disease ( include untreated HTN ) , respiratory disease , cerebrovascular disease , intracranial HTN ( include glaucoma ) , seizures Presence foreign body ( include pacemaker ) Pregnancy Allergies anesthetic use study Includes : ) Ketamine b ) Propofol c ) Eggs ) Egg product e ) Soybeans f ) Soy product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>MDD</keyword>
	<keyword>Treatment Resistant Depression</keyword>
	<keyword>Electroconvulsive Therapy</keyword>
	<keyword>ECT</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Propofol</keyword>
	<keyword>NMDA</keyword>
</DOC>